By Exec Edge Editorial Staff
When a Georgia jury ordered Bayer to pay $2.1 billion to a single plaintiff in March 2025, the verdict sent shockwaves through both the pesticide industry and the MAHA movement. The award—$65 million in compensatory damages and $2 billion in punitive damages—was the largest single-plaintiff verdict in Georgia history.
For Make America Healthy Again (MAHA) advocates, the verdict represents validation of the movement’s concerns about pesticide safety. For the pesticide industry, it represents an existential threat that has prompted aggressive lobbying for legislative immunity.
The Case
John Barnes used Roundup weedkiller at his home and workplace for over 20 years before being diagnosed with non-Hodgkin lymphoma. His lawsuit alleged that Bayer’s Monsanto subsidiary knew Roundup’s active ingredient, glyphosate, posed cancer risks but failed to warn consumers.
The jury agreed. While Bayer has announced plans to appeal, the verdict followed a pattern of massive awards in Roundup litigation. Between 2023 and 2025, plaintiffs have won nearly $5 billion in verdicts, though some were later reduced by judges.
The Broader Litigation
Bayer acquired Monsanto in 2018, inheriting a legal crisis that has since cost the company over $10 billion in settlements. As of January 2026, approximately 65,000 Roundup lawsuits remain pending, with new cases still being filed. The company has reportedly set aside $16 billion to settle the remaining cases.
Recent developments include a Missouri appellate court upholding a $611 million verdict in May 2025 and a California appeals court affirming a $28 million verdict in November 2025. Bayer has won 17 of the last 25 cases that reached judgment at trial, but the losses have been substantial.
The MAHA Connection
The MAHA Commission Assessment, released in May 2025, directly addresses pesticide concerns. The report notes that glyphosate research has found “a range of possible health effects, ranging from reproductive and developmental disorders as well as cancers, liver inflammation and metabolic disturbances.”
The Assessment also highlights corporate influence on pesticide research, noting that studies finding harm are more likely to come from non-industry sources, while industry-funded research tends to declare products safe. This pattern mirrors concerns about corporate capture of regulatory agencies that the MAHA movement has consistently raised.
The Legislative Battle
Facing billions in potential liability, Bayer has pursued legislative solutions at both state and federal levels. The company is pushing bills that would protect pesticide manufacturers from failure-to-warn lawsuits beyond federal labeling requirements.
In Georgia, just days after the $2 billion verdict, the legislature passed SB144, which would protect pesticide manufacturers from liability for not warning consumers of health risks beyond what federal labels require. Governor Brian Kemp has not yet signed the bill and is facing pressure to veto it.
Similar legislation is advancing in Idaho, Iowa, Missouri, Mississippi, Montana, North Dakota, Oklahoma, and Tennessee. MAHA activists have mobilized against these bills, which they characterize as granting immunity to companies whose products may cause cancer.
The most high-profile MAHA victory came in January 2026, when grassroots pressure helped strip Section 453—a provision granting pesticide manufacturers immunity from failure-to-warn lawsuits—from the FY2026 Interior-Environment Appropriations Bill.
What’s Next
In February 2026, Bayer took its biggest step yet toward resolving the litigation, proposing a $7.25 billion class-action settlement to cover the majority of the approximately 65,000 remaining Roundup lawsuits. A Missouri state court judge granted preliminary approval on March 4, 2026, with individual payouts expected to range from $6,000 to $165,000 and settlement funding structured over up to 21 years. Class members have until June 4 to opt out, and a final fairness hearing is scheduled for July 9.
The settlement is just one prong of Bayer’s strategy to cap its liability — which has already exceeded $10 billion — by the end of 2026. The company has also petitioned the US Supreme Court to rule that federal labeling laws preempt state failure-to-warn claims, which could effectively end future litigation. Months after filing, the Court has not indicated whether it will take the case.
For MAHA advocates, the Roundup saga represents both a vindication and a warning. The verdicts demonstrate that juries believe pesticide manufacturers failed to adequately warn consumers about health risks. But the aggressive push for legislative immunity — and a settlement structure that could pay individual plaintiffs as little as $6,000 — shows that corporate interests can rapidly mobilize to limit accountability.
The Bigger Picture
The Roundup case sits at the intersection of several MAHA concerns: environmental chemicals in food production, corporate influence on scientific research, regulatory capture, and the need for transparent safety data.
The MAHA Commission report notes that more than eight billion pounds of pesticides are used in global food production annually, with the US accounting for roughly 11% of that total. While federal agencies have found the majority of food samples compliant with safety limits, the Roundup litigation raises questions about whether those limits adequately protect public health.
For families concerned about pesticide exposure, the $2 billion verdict sends a clear message: juries are willing to hold manufacturers accountable when they believe consumers weren’t adequately warned about health risks. Whether that accountability survives legislative and judicial challenges remains to be seen.
READ MORE
2nd Princeton CorpGov Forum Preliminary Speakers for May 21
Never Miss our Weekly Highlights HERE
